Phase 2 data finds OCS-01 improves macular thickness, VA in DME patients
OCS-01 is a novel, high concentration, preservative free, topical formulation of dexamethasone that has the potential to be the first topical eye drop and non-invasive treatment for DME.
Study: Inconclusive results on glasses wear and coronavirus infection
The jury is still out on whether wearing glasses is associated with a decreased risk of COVID-19 infections.
FDA accepts NDA of NOV03 for DED associated with MGD
Bausch + Lomb and Novaliqu announced that the FDA has accepted its New Drug Application for NOV03, an investigational treatment for dry eye disease associated with meibomian gland dysfunction.
Accessible at-home COVID-19 tests are designed with visually impaired, blind individuals in mind
These new testing kits permit more equitable access to coronavirus testing.
Comanaging tears in Descemet membrane during cataract surgery
Postoperative scenario tracks potential complications.
COVID-19 vaccination can contribute to corneal allograft rejection
Japanese researchers conducted a systematic review that identified clinical features and host factors associated with corneal allograft rejection after COVID-19 vaccination.
Study: Hearing, visually impaired adults less likely to be vaccinated for COVID-19
A recent study shows US adults with hearing and visual impairments have lower rates of vaccination for the coronavirus.
SCOPA 2022: Low vision considerations, treatments, and tools
Jamie Ho, OD, FAAO, FCOVD, shares highlights from her SCOPA 2022 presentation, "Tools and considerations for low vision rehabilitation."
SCOPA 2022: Concussion education for the OD
Jamie Ho, OD, FAAO, FCOVD, shares highlights from her SCOPA 2022 presentation, "Concussion for the primary care optometrist."
SCOPA 2022: All things abnormal pupil
Brad Sutton, OD, FAAO, FORS, shares highlights from his SCOPA 2022 presentation, "Taking the mystery out of abnormal pupils."
SCOPA 2022: Anterior segment laser procedures
Brad Sutton, OD, FAAO, FORS, shares highlights from his SCOPA 2022 presentation, "Anterior segment laser procedures."
Reviewing the latest contact lens launches
Check out expert insight on the most recent lens launches to expand the options accessible to our patients based on their specific needs.
SCOPA 2022: A look into sleep apnea and the eye
Brad Sutton, OD, FAAO, FORS, shares highlights from his SCOPA 2022 presentation, "Sleep apnea and the eye."
SCOPA 2022: A review of topical medication classes in eyecare
Brad Sutton, OD, FAAO, FORS, shares highlights from his SCOPA 2022 presentation, "Topical Pharmacology Rounds."
Apellis releases 24-month results of phase 3 studies for GA treatment
Latest data from phase 3 studies finds increased effects over time with intravitreal pegcetacoplan for geographic atrophy secondary to age-related macular degeneration.
Alcon to acquire Aerie Pharma, expanding ophthalmic pharma portfolio
Latest transaction, totaling approximately $770 million, adds key commercial products and clinical/preclinical product candidates in the pipeline.
Navigating telehealth in a postpandemic era
Establish a program in your practice during this Wild West phase of tech.
AAO, AAOF announce 2022 award recipients
Results are in for this year's award recipients!
NIH-funded clinical trial results support “step therapy” for DME treatment
A recent clinical trial from the DRCR Retina Network examined a stepped regimen of anti-VEGF drugs bevacizumab and aflibercept.
Report: ortho-K expected to surge over next 2 years
Published in Optometry & Visual Sciences, the findings are based on an independent survey featuring feedback from over 500 US eye care professionals.
